Vaccine Development

From Concept to Clinic

Buch | Hardcover

322 Seiten

2022
Royal Society of Chemistry (Verlag)
978-1-78801-877-7 (ISBN)

Artikel merken

Utilising successful case studies Vaccine Development will provide insight to the issues scientists face when producing a vaccine, the steps involved and will serve as an ideal reference tool regarding state-of-the-art vaccine development.

Vaccine development is a complex and time consuming process that differs from the development of conventional pharmaceuticals. Primarily, vaccines are intended for use in healthy individuals as a preventative measure, requiring a long and rigorous process of research and many years of testing and development prior to clinical trials and regulatory approval. The average time for the development of vaccines to clinical is 12 to 15 years. Vaccine Development: From Concept to Clinic is a detailed overview of the development of new vaccines, covering the entire process and addresses all classes of vaccines from a processing, development and regulatory viewpoint. Utilising successful case studies the book will provide insight to the issues scientists face when producing a vaccine, the steps involved and will serve as an ideal reference tool regarding state-of-the-art vaccine development. This book is an ideal companion for any researchers working in vaccine discovery and development or with an interest in the field.

Citranvi LLC., USA

Vaccine Development: From Concept to Clinic;

Pre-clinical Safety Assessment Considerations for Vaccine Development;

Clinical Trials in the Development of Vaccines for Infectious Diseases;

Clinical Trials in Immunotherapeutic Vaccine Development;

Pathogenesis and Immunity of SARS-CoV-2 and Vaccination Programs against COVID-19;

High Throughput Assays for Clinical Development;

Virus-like Particle Based Vaccines: GARDASIL®;

Cell Culture-based Influenza Vaccine Development;

Conjugate Vaccines: Design and Development Considerations;

Vaccine Adjuvants: Mechanisms of Action;

Development Considerations for Final Dosage Forms: Mucosal Bacterial Vaccines;

Exploiting Glycans in Vaccine Design;

The PATH Experience in Vaccine Development Partnerships with Manufacturers from Emerging Markets

Erscheinungsdatum	10.11.2022
Reihe/Serie	Drug Development and Pharmaceutical Science ; Volume 3
Verlagsort	Cambridge
Sprache	englisch
Maße	156 x 234 mm
Gewicht	1777 g
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie
	Medizin / Pharmazie ► Pharmazie
	Naturwissenschaften ► Chemie ► Organische Chemie
	Naturwissenschaften ► Chemie ► Technische Chemie
	Technik
ISBN-10	1-78801-877-X / 178801877X
ISBN-13	978-1-78801-877-7 / 9781788018777
Zustand	Neuware